Article
IFNα2b modulates anti-tumor immune responses involving STAT3-associated dendritic cell dysfunction in JAK2v617f-positive myeloproliferative neoplasms.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy - 1 Mar 2026
Fang Lijun, Fu Rongfeng, Dong Huan, Zhang Wenhui, Gao Yuchen, Xu Yanmei, Gu Wenjing, Liu Zixuan, Li Huiyuan, Wang Wentian, Pei Xiaolei, Chi Ying, Zhou Yuan, Wei Jun, Wang Ying, Zhang Lei
Abstract excerpt
AIMS: To define JAK2v617f-induced immune alterations, focusing on STAT3-mediated dendritic cell dysfunction, and evaluate whether IFNα2b restores anti-tumor immunity in JAK2v617f-positive myeloproliferative neoplasms. METHODS: Integrated flow cytometry and single-cell RNA sequencing profiled immune landscapes and signaling pathways, while functional assays assessed dendritic cell differentiation, T cell...
Topics
Join the communities discussing this publication.
